Evidence map›Paper›PMID 35171249›Full record

ArticleJournal of the National Cancer Institute2022

Workforce Caring for Cancer Survivors in the United States: Estimates and Projections of Use.

Angela B Mariotto, Lindsey Enewold, Helen Parsons, Christopher A Zeruto, K Robin Yabroff, Deborah K Mayer

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prevalence of cancer survivors in the United States.Journal of the National Cancer Institute · 2024
    Article
  6. Article
  7. Article
  8. Overcoming Obstacles in Transitions of Cancer Survivor Care.Journal of the National Cancer Institute · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Angela B MariottoDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0003-2423-1834
Lindsey EnewoldDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0003-0452-5771
Helen ParsonsDivision of Health Policy and Management, University of Minnesota, Minneapolis, MN, USA.
Christopher A ZerutoInformation Management Services, Inc, Calverton, MD, USA.
K Robin YabroffSurveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.ORCID 0000-0003-0644-5572
Deborah K MayerDivision  of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aims to quantify the extent and diversity of the cancer care workforce, beyond medical oncologists, to inform future demand because the number of cancer survivors is expected to grow in the United States.

methodsSurveillance, Epidemiology, and End Results-Medicare data were used to evaluate health-care use of cancer survivors diagnosed between 2000 and 2014, enrolled in fee-for-service Medicare Parts A and B, and 65 years or older in 2008-2015. We calculated percentage of cancer survivors who saw each clinician specialty and their average annual number of visits in each phase of care. We projected the national number of individuals receiving care and number of annual visits by clinician specialty and phase of care through 2040.

resultsCancer survivors had higher care use in the first year after diagnosis and last year of life phases. During the initial year after cancer diagnosis, most survivors were seen for cancer-related care by a medical oncologist (59.1%), primary care provider (55.9%), and/or other cancer-treating physicians (42.2%). The percentage of survivors with cancer-related visits to each specialty declined after the first year after diagnosis, plateauing after year 6-7. However, at 10 or more years after diagnosis, approximately 20% of cancer survivors had visits to medical oncologists and an average of 4 visits a year.

conclusionsCancer survivors had higher care use in the first year after diagnosis and last year of life. High levels of care use across specialties in all phases of care have important implications for models of survivorship care coordination and workforce planning.

Indexed as

Cancer SurvivorsNeoplasmsAgedHumansMedicareSurvivorsSurvivorshipUnited StatesWorkforce

Identifiers

PMID35171249
PMCPMC9194628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.